Keyphrases
2-year Follow-up
19%
Abdominal Obesity
42%
Antipsychotics
78%
Bidirectional Association
16%
Cardiorespiratory Fitness
17%
Cardiovascular Risk
63%
Care Coordination
50%
Cause of Death
26%
Clinical Analysis
50%
Confidence Interval
23%
Depression Severity
20%
Exercise Effect
23%
First-episode Psychosis
55%
Functional Outcome
16%
Gut Microbiota
33%
Healthy Controls
22%
Homelessness
16%
Hospitalization
16%
Lessons Learned
16%
Life Expectancy
19%
Lifestyle Coaching
50%
Major Depressive Disorder
38%
Mental Disorders
23%
Meta-analysis
56%
Mortality Prediction
16%
Nationwide Registers
33%
Negative Symptoms
21%
Obesity
26%
Patients with Schizophrenia
48%
People with Schizophrenia
19%
Physical Activity
22%
Psychiatric Disorders
16%
Psychiatric Hospitalization
18%
Psychosis
17%
Psychotic Disorders
22%
Randomized Clinical Trial
51%
Randomized Controlled Trial
22%
Recovery Rate
16%
Register Study
33%
Regression Analysis
24%
Remission
28%
Risk Reduction
33%
Schizophrenia
81%
Schizophrenia Spectrum Disorders
70%
Severe Mental Illness
39%
Spectrum Diagnosis
16%
Systematic Meta-analysis
100%
Treatment as Usual
53%
Tyrosine Biosynthesis
16%
Waist Circumference
40%
Medicine and Dentistry
Abdominal Obesity
43%
Adverse Event
14%
Body Mass Index
22%
Cardiorespiratory
23%
Cardiovascular Disease
50%
Cardiovascular Risk
30%
Care Coordination
50%
Cognitive Defect
16%
Cohort Analysis
16%
Dietary Habit
12%
Dietary Pattern
16%
Differential Diagnosis
16%
Disease
19%
Drug Therapy
32%
Glucose Metabolism
16%
Gut
19%
Gut Microbiome
16%
Gut Microbiota
33%
Hemoglobin A1c
16%
High-Density Lipoprotein
16%
Insulin Resistance
16%
Life Expectancy
23%
Lifestyle Intervention
16%
Maintenance Therapy
16%
Major Depressive Episode
22%
Malignant Neoplasm
16%
Mediator
16%
Mental Disorder
33%
Meta-Analysis
40%
Meta-Regression
36%
Mood Disorder
16%
Negative Syndrome
22%
Obesity
24%
Patient Social Context
16%
Patient with Overweight
16%
Personality Disorder
16%
Physical Activity
26%
Population
28%
Psychosis
33%
Randomized Clinical Trial
50%
Randomized Controlled Trial
16%
Schizophrenia Spectrum Disorder
58%
Sequential Analysis
33%
Severe Mental Illness
16%
Substance Use
16%
Symptom
36%
Systematic Review
60%
Systematic Review with Meta-Analysis
33%
Treatment Effect
20%
Weight Management
16%
